Effects of modified low-density lipoproteins on human retinal pericyte survival

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 390-395

  Song, Weiwei ^a,c   Barth, Jeremy L ^b   Lu, Kangmo ^a   Yu, Yongxin ^a   Huang, Yan ^c   Gittinger, Cynthia K ^b   Argraves, W Scott ^b   Lyons, Timothy J ^a,d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Diabetic retinopathy; Modified LDL; Oxidized LDL; Pericyte; Vascular smooth muscle

Indexed keywords

DNA FRAGMENT; LOW DENSITY LIPOPROTEIN;

APOPTOSIS; CAPILLARY LEAK SYNDROME; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CYTOTOXICITY; DIABETIC RETINOPATHY; EXTRAVASATION; GLYCATION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; NERVE CELL CULTURE; PERICYTE; PROTEIN MODIFICATION; RETINA CELL; VASCULAR SMOOTH MUSCLE;

BOVINAE;

EID: 23744457465     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1333.045     Document Type: Conference Paper

References (16)

1. KUWABARA, T. & D.G. COGAN. 1963. Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch. Ophthalmol. 69: 492-502.
2. LYONS, T.J., J.W. BAYNES, J.S. PATRICK, et al. 1986. Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia 29: 685-689.
3. LYONS, T.J. 1993. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am. J. Cardiol. 71: 26B-31B.
4. TSAI, E.C., I.B. HIRSCH, J.D. BRUNZELL & A. CHAIT. 1994. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014.
5. LYONS T.J. & A.J. JENKINS. 1997. Lipoprotein glycation and its metabolic consequences. Curr. Opin. Lipidol. 8: 174-180.
6. LYONS T.J., W. LI, M.C. WELLS-KNECHT & R. JOKL. 1994. Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabetes 43: 1090-1095.
7. CHISOLM, G.M. & D. STEINBERG. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28: 1815-1826.
8. IMANAGA, Y., N. SAKATA, S. TAKEBAYASHI, et al. 2000. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis 150: 343-355.
9. JENKINS, A.J., V. VELARDE, R.L. KLEIN, et al. 2000. Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49: 2160-2169.
10. WYLLIE, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
11. TAGUCHI, S., T. OINUMA & T. YAMADA. 2000. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation. J. Atheroscler. Thromb. 7: 132-137.
12. ASMIS, R. & J.G. BEGLEY. 2003. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ. Res. 92: e20-29.
13. SALVAYRE, R., N. AUGE, H. BENOIST & A. NEGRE-SALVAYRE. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585: 213-221.
14. NAPOLI, C. 2003. Oxidation of LDL, atherogenesis, and apoptosis. Ann. N.Y. Acad. Sci. 1010: 698-709.
15. ARTWOHL, M., W.F. GRAIER, M. RODEN, et al. 2003. Diabetic LDL triggers apoptosis in vascular endothelial cells. Diabetes 52: 1240-1247.
16. DE NIGRIS, F., G. TAJANA, M. CONDORELLI, et al. 2003. Glycoxidation of low-density lipoprotein increases TUNEL positivity and CPP32 activation in human coronary cells. Ann. N.Y. Acad. Sci. 1010: 710-715.